Daiichi Sankyo FY20 Profit Down; Sees Higher Operating Profit, Revenues In FY21

Daiichi Sankyo Co. Ltd. (DSKYF.PK), a Japanese pharmaceutical company, reported Tuesday that its fiscal 2020 profit attributable to owners of the company declined 41.2 percent to 75.96 billion yen from the prior year's 129.07 billion yen. Earnings per share fell to 39.11 yen from 66.27 yen last year.

Operating profit declined 54 percent year on year to 63.80 billion yen.

Revenue for the period dropped 2 percent to 962.52 billion yen from last year's 981.79 billion yen.

Looking ahead for fiscal 2021, the company expects attributable profit of 50 billion yen or 26.09 yen, down 34.2 percent year-over-year. Operating profit is expected to be 70 billion yen, up 9.7 percent, while core operating profit would be down 11.2 percent to 70 billion yen.

Revenue for the year is estimated to be 990 billion yen, up 2.9 percent from the previous year.

In Japan, Daiichi Sankyo shares traded at 2,905 yen, down 3.5 percent.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration approved Regeneron Pharmaceuticals, Inc.'s Dupixent (dupilumab) to treat eosinophilic esophagitis or EoE, a chronic immune disorder. It is the first FDA approval to treat EoE in adults and pediatric patients 12 years and older weighing at least 40 kilograms. Food products maker J. M. Smucker Co. has recalled select Jif peanut butter products sold in the United States due to potential Salmonella contamination, the U.S. Food and Drug Administration said. The recall involves various creamy, crunchy, natural, no added sugar, and reduced fat peanut butter, among others with lot codes 1274425 - 2140425. Smithfield Packaged Meats Corp. is recalling around 185,610 pounds of ready-to-eat or RTE bacon topping products citing the possible contamination with extraneous materials, specifically metal, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced.
Follow RTT